WNK1 and breast cancer: This study also shows that bone-derived OPN activates a downstream signaling response in breast cancer cells involving the phosphorylation of WNK-1 and PRAS40, and that these pathways contribute to enhanced migration of breast cancer cells in the context of the soluble bone microenvironment.